USA Shipped · Chino, California
Research Use Only Products are for laboratory research only, not for human or animal consumption. Research Compliance
Research Reference

Ara-290 Research Reference

Complete research reference and reconstitution guide for Ara-290.

Research Use Only Reconstitution Math Storage Reference

Quick Reference

Vial Amount
10mg
CoreVials Standard Mix
Add 1 mL (100 units) BAC Water
Final Concentration
10 mg/mL
Easy Reference
10 units = 1 mg
Storage
Refrigerate after reconstitution

This page is for research-use-only educational reference and measurement math. It is not medical, veterinary, dosing, administration, or treatment guidance. Products are not for human or animal consumption.

On this page

How This Works

Ara-290 (cibinetide) binds to the innate repair receptor (IRR), a heterodimer of EPOR and CD131 (βc subunit), which is distinct from the classical erythropoietin receptor[1][2]. This selective binding triggers anti-apoptotic and anti-inflammatory signaling cascades that protect tissues and promote repair without stimulating erythropoiesis[9]. Preclinical research demonstrates that Ara-290 can reprogram a pro-inflammatory, tissue-damaging environment into one favoring healing and regeneration[10]. Additionally, analgesic effects have been observed through immunomodulation and direct inhibition of TRPV1 ion channels activated by capsaicin[11].

CoreVials Standard Mix

For a 10mg vial Add 1 mL (100 units) BAC Water
Final concentration 10 mg/mL

After mixing (U-100 syringe reference)

  • 5 units=0.5 mg
  • 10 units=1 mg
  • 20 units=2 mg

These are example measurement calculations only. They are not dosing, administration, medical, or veterinary guidance.

Other Mix Options
BAC Added Final Concentration Dose per 10 units
1 mL (100 units) CoreVials Standard Mix 10 mg/mL 1 mg
2 mL (200 units) 5 mg/mL 0.50 mg

Supply Planning

Products commonly paired for research preparation:

  • Ara-290 Research Reference
  • BAC Water
  • Cryo labels
  • Storage case

References

IUPHAR/BPS Guide to Pharmacology
— Cibinetide (ARA-290) ligand profile: structure, receptor binding, and pharmacology

Molecular Medicine (2008)
— Brines & Cerami: Discovery and development of the innate repair receptor and its non-erythropoietic ligands

View Source

Molecular Medicine (2014)
— Brines M. et al.: ARA 290 improves metabolic control and neuropathic symptoms in research samples with type 2 diabetes

Molecular Medicine (2013)
— Dahan A. et al.: ARA 290 improves symptoms in sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density

ClinicalTrials.gov (NCT02039687)
— Phase 2 study of ARA 290 on corneal nerve fiber density in sarcoidosis (1 mg vs 4 mg vs 8 mg daily SC for 28 days)

NCBI Bookshelf
— Stability and storage considerations for lyophilized peptide formulations

USP General Chapters
— Pharmaceutical compounding with bacteriostatic water: stability and beyond-use dating

Cleveland Clinic
— measurements: where and how to prepare at home

Pain Reports (2017)
— Davis T. et al.: Targeting the innate repair receptor to treat neuropathy (review of ARA-290 mechanisms)

Investigative Ophthalmology & Visual Science (2016)
— Cibinetide improves corneal nerve fiber abundance in research samples with sarcoidosis-associated small fiber neuropathy

Peptides Journal (2016)
— Zhang W. et al.: ARA 290 relieves pathophysiological pain by targeting TRPV1 channel

Johns Hopkins Arthritis Center
— How to give a measurement: research sample guide

CDC
— Vaccine preparation: route (angle, site, and technique guidance)

PMC Drug Delivery Review
— Pharmacologic considerations of the measurement route

Research Use Notice

This page is research-use-only educational reference and measurement math. It is not medical, veterinary, dosing, administration, or treatment guidance. Products are not for human or animal consumption.

Need research supplies?

High-purity peptides and lab essentials with batch-level COA transparency.

Research Use Only Products are for laboratory research only, not for human or animal consumption. Research Compliance